You are here

  • Home
  • Archive
  • Volume 3, Issue Suppl 2
  • Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy

Article metrics

Article menu

Download PDFPDF

Poster Presentation
Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy

 

Online download statistics by month:

Online download statistics by month: December 2019 to October 2024

AbstractFullPdf
Dec 2019010
Jan 2020020
Feb 2020010
May 2020010
Jun 2020070
Jul 2020030
Aug 2020010
Sep 2020090
Oct 2020010
Nov 2020060
Dec 2020021
Jan 2021032
Feb 2021011
Mar 2021020
Apr 2021020
May 2021021
Jun 2021020
Jul 2021020
Aug 2021011
Sep 2021051
Oct 2021042
Nov 2021010
Dec 2021040
Jan 2022040
Feb 2022020
Mar 2022010
Apr 2022011
May 2022030
Jun 2022020
Jul 2022020
Aug 2022042
Sep 2022040
Oct 2022050
Nov 2022031
Dec 2022060
Jan 2023030
Feb 2023010
Mar 2023030
Apr 2023010
May 2023020
Jun 2023011
Jul 2023021
Sep 2023020
Oct 2023011
Nov 2023053
Dec 2023081
Jan 2024030
Feb 2024030
Mar 20240239
Apr 2024038
May 20240312
Jun 2024071
Jul 2024051
Aug 2024020
Sep 2024052
Oct 2024033
Total016586